
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut microbiota-derived tryptophan metabolism mediates renal fibrosis by aryl hydrocarbon receptor signaling activation
Jingru Liu, Hua Miao, Deqiang Deng, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 3, pp. 909-922
Closed Access | Times Cited: 139
Jingru Liu, Hua Miao, Deqiang Deng, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 3, pp. 909-922
Closed Access | Times Cited: 139
Showing 1-25 of 139 citing articles:
The links between gut microbiota and obesity and obesity related diseases
Jiafeng Geng, Qingqiang Ni, Wei Sun, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112678-112678
Open Access | Times Cited: 228
Jiafeng Geng, Qingqiang Ni, Wei Sun, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 147, pp. 112678-112678
Open Access | Times Cited: 228
Fibrosis: Types, Effects, Markers, Mechanisms for Disease Progression, and Its Relation with Oxidative Stress, Immunity, and Inflammation
Samar A. Antar, Nada A. Ashour, Mohamed E. Marawan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4004-4004
Open Access | Times Cited: 133
Samar A. Antar, Nada A. Ashour, Mohamed E. Marawan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4004-4004
Open Access | Times Cited: 133
Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome
Lin Xiao, Qin Liu, Mei Luo, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 107
Lin Xiao, Qin Liu, Mei Luo, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 107
Microbiota-derived metabolite Indoles induced aryl hydrocarbon receptor activation and inhibited neuroinflammation in APP/PS1 mice
Jing Sun, Yuhe Zhang, Yu Kong, et al.
Brain Behavior and Immunity (2022) Vol. 106, pp. 76-88
Open Access | Times Cited: 102
Jing Sun, Yuhe Zhang, Yu Kong, et al.
Brain Behavior and Immunity (2022) Vol. 106, pp. 76-88
Open Access | Times Cited: 102
Tryptophan Metabolism and Gut Microbiota: A Novel Regulatory Axis Integrating the Microbiome, Immunity, and Cancer
Yingjian Hou, Jing Li, Shuhuan Ying
Metabolites (2023) Vol. 13, Iss. 11, pp. 1166-1166
Open Access | Times Cited: 47
Yingjian Hou, Jing Li, Shuhuan Ying
Metabolites (2023) Vol. 13, Iss. 11, pp. 1166-1166
Open Access | Times Cited: 47
The role of gut microbiota in intestinal disease: from an oxidative stress perspective
Yiqi Sun, Xurui Wang, Lei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 36
Yiqi Sun, Xurui Wang, Lei Li, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 36
Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats
Li Cheng, Xulong Chen, Jingchun Yao, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314029-e0314029
Open Access | Times Cited: 2
Li Cheng, Xulong Chen, Jingchun Yao, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0314029-e0314029
Open Access | Times Cited: 2
Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance
A. Yu. Grishanova, M. L. Perepechaeva
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6719-6719
Open Access | Times Cited: 66
A. Yu. Grishanova, M. L. Perepechaeva
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6719-6719
Open Access | Times Cited: 66
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
Xiao-Yong Yu, Qian Sun, Yamei Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Xiao-Yong Yu, Qian Sun, Yamei Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 52
Host/microbiota interactions-derived tryptophan metabolites modulate oxidative stress and inflammation via aryl hydrocarbon receptor signaling
Yue-Qi Tan, Yanni Wang, Hao-Yu Feng, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 30-41
Closed Access | Times Cited: 46
Yue-Qi Tan, Yanni Wang, Hao-Yu Feng, et al.
Free Radical Biology and Medicine (2022) Vol. 184, pp. 30-41
Closed Access | Times Cited: 46
Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life?
Chien‐Ning Hsu, You‐Lin Tain
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3954-3954
Open Access | Times Cited: 41
Chien‐Ning Hsu, You‐Lin Tain
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3954-3954
Open Access | Times Cited: 41
Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease
Joachim Neumann, Britt Hofmann, Stefan Dhein, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4765-4765
Open Access | Times Cited: 41
Joachim Neumann, Britt Hofmann, Stefan Dhein, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4765-4765
Open Access | Times Cited: 41
The roles of gut microbiota and its metabolites in diabetic nephropathy
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 27
Hui Zhao, Cheng-E Yang, Tian Liu, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 27
Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Dongwei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Dongwei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
The Engagement of Cytochrome P450 Enzymes in Tryptophan Metabolism
Anna Haduch, Ewa Bromek, Wojciech Kuban, et al.
Metabolites (2023) Vol. 13, Iss. 5, pp. 629-629
Open Access | Times Cited: 23
Anna Haduch, Ewa Bromek, Wojciech Kuban, et al.
Metabolites (2023) Vol. 13, Iss. 5, pp. 629-629
Open Access | Times Cited: 23
Uremic toxins mediate kidney diseases: the role of aryl hydrocarbon receptor
Hongyan Xie, Ninghao Yang, Chen Yu, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 11
Hongyan Xie, Ninghao Yang, Chen Yu, et al.
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 11
Schisandrin A alleviates renal fibrosis by inhibiting PKCβ and oxidative stress
Huiling Liu, Zhou Huang, Qing-Zhen Li, et al.
Phytomedicine (2024) Vol. 126, pp. 155372-155372
Closed Access | Times Cited: 8
Huiling Liu, Zhou Huang, Qing-Zhen Li, et al.
Phytomedicine (2024) Vol. 126, pp. 155372-155372
Closed Access | Times Cited: 8
The tryptophan metabolic pathway of the microbiome and host cells in health and disease
Kentaro Miyamoto, Tomohisa Sujino, Takanori Kanai∥
International Immunology (2024)
Open Access | Times Cited: 8
Kentaro Miyamoto, Tomohisa Sujino, Takanori Kanai∥
International Immunology (2024)
Open Access | Times Cited: 8
The AHR–NRF2–JDP2 gene battery: Ligand–induced AHR transcriptional activation
Kenly Wuputra, Wen-Hung Hsu, Chia‐Chen Ku, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116761-116761
Open Access | Times Cited: 1
Kenly Wuputra, Wen-Hung Hsu, Chia‐Chen Ku, et al.
Biochemical Pharmacology (2025) Vol. 233, pp. 116761-116761
Open Access | Times Cited: 1
Advancements in the Pathogenesis, Diagnosis, and Therapeutic Implications of Intestinal Bacteria
Dai Lu, Xianxiong Ma, Kaixiong Tao, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 106-106
Open Access | Times Cited: 1
Dai Lu, Xianxiong Ma, Kaixiong Tao, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 106-106
Open Access | Times Cited: 1
Shenkang Injection and Its Three Anthraquinones Ameliorates Renal Fibrosis by Simultaneous Targeting IƙB/NF-ƙB and Keap1/Nrf2 Signaling Pathways
Liang-Pu Luo, Ping Suo, Lili Ren, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 52
Liang-Pu Luo, Ping Suo, Lili Ren, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 52
The Role of Gut Microbiota and Microbiota-Related Serum Metabolites in the Progression of Diabetic Kidney Disease
Qing Zhang, Yanmei Zhang, Lu Zeng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 46
Qing Zhang, Yanmei Zhang, Lu Zeng, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 46
Fisetin Improves Hyperuricemia-Induced Chronic Kidney Disease via Regulating Gut Microbiota-Mediated Tryptophan Metabolism and Aryl Hydrocarbon Receptor Activation
Qian Ren, Lu Cheng, Fan Guo, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 37, pp. 10932-10942
Closed Access | Times Cited: 43
Qian Ren, Lu Cheng, Fan Guo, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 37, pp. 10932-10942
Closed Access | Times Cited: 43
Gut Microbiome and Organ Fibrosis
Carolina F. F. A. Costa, Benedita Sampaio‐Maia, Ricardo Araújo, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 352-352
Open Access | Times Cited: 37
Carolina F. F. A. Costa, Benedita Sampaio‐Maia, Ricardo Araújo, et al.
Nutrients (2022) Vol. 14, Iss. 2, pp. 352-352
Open Access | Times Cited: 37
Tryptophan intake, not always the more the better
Dongmei Hu, Junyi Liu, Wanlin Yu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 20
Dongmei Hu, Junyi Liu, Wanlin Yu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 20